205 related articles for article (PubMed ID: 3630094)
21. [Results of a controlled clinical protocol in the treatment of patients with operable breast carcinoma with positive axillary lymph nodes. Comparison of a chemotherapeutic regimen with a chemo-immunotherapeutic regimen].
Mantovani G; Coiana A; Zucca MV; Sanna GP; Floris C; Sulis E; Del Giacco GS
Recenti Prog Med; 1988 Dec; 79(12):513-8. PubMed ID: 3241904
[No Abstract] [Full Text] [Related]
22. [Use of thymopentin in the treatment of post-radiation cystitis].
Martinoli F; Catania G; Bertana F; Caldera G
Minerva Urol Nefrol; 1988; 40(4):275-6. PubMed ID: 3075095
[No Abstract] [Full Text] [Related]
23. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
24. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
[No Abstract] [Full Text] [Related]
25. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
26. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
[No Abstract] [Full Text] [Related]
27. Thymopentin in dermatology.
Haneke E
Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
[No Abstract] [Full Text] [Related]
28. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases].
Petrunia AM; Enenko IuA
Lik Sprava; 1996; (3-4):125-7. PubMed ID: 9035846
[TBL] [Abstract][Full Text] [Related]
30. [Criteria for evaluation of the efficacy of immunotherapy of bronchiectasis patients].
Gubergrits AIa; Monogarova NE; Sokhin AA
Vrach Delo; 1986 May; (5):89-91. PubMed ID: 3727521
[No Abstract] [Full Text] [Related]
31. [Thymopentin in the treatment of recurrent condylomata acuminata].
Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
[TBL] [Abstract][Full Text] [Related]
32. [Immunotherapy with high-dose thymostimulin in patients with advanced neoplasms].
Marcellino LR; Stellato L; Franchi F; Bandini M; Ceccarelli P; Agatensi L
G Ital Oncol; 1988; 8(1):45-7. PubMed ID: 3220512
[No Abstract] [Full Text] [Related]
33. [The immunomodulating action of vilozen and splenin in angina patients against a background of chronic bronchitis].
Frolov VM; Peresadin NA; Ershova IB; Demenkov VR; Miakina AV
Lik Sprava; 1992 Aug; (8):79-81. PubMed ID: 1475936
[TBL] [Abstract][Full Text] [Related]
34. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
Ivanova LA
Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
[TBL] [Abstract][Full Text] [Related]
36. [Role of an immunomodulator in oncologic surgery: possibilities and limitations].
Butti A; Cotogni P; Amato A
Chir Patol Sper; 1984 Oct; 32(5):215-27. PubMed ID: 6443782
[No Abstract] [Full Text] [Related]
37. Thymopentin in chronic Trichophyton rubrum infection.
Molin L; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
[TBL] [Abstract][Full Text] [Related]
38. [Changes in histamine metabolism during treatment of hepatitis B patients with splenin].
Mitchenko IK; Slobodianiuk MI; Degtiarenko OM; Shevchenko AV; Tiuleneva GV
Vrach Delo; 1984 May; (5):120-1. PubMed ID: 6741074
[No Abstract] [Full Text] [Related]
39. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Faist E; Riedel A; Bolla K
Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
[TBL] [Abstract][Full Text] [Related]
40. [Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis].
Salvati F
Recenti Prog Med; 1989 Sep; 80(9):499. PubMed ID: 2687987
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
